指南与共识外周动脉疾病

非对比磁共振血管成像在慢性肢体威胁性缺血膝下动脉评估中优于数字减影血管造影

Noncontrast magnetic resonance angiography outperforms digital subtraction angiography in detecting hibernating below-the-knee arteries and downgrades Transatlantic Inter-Society Consensus and Global Limb Anatomic Staging System scores in chronic limb-threatening ischemia patients.
指南 / 共识 · J Vasc Surg · 2025-10-14

该研究纳入41例接受QISS MRI与DSA检查的慢性肢体威胁性缺血(CLTI)患者,比较两种方法对腘动脉及膝下动脉的通畅性评估及TASC II与GLASS分级。结果显示QISS MRI识别的通畅血管节段显著多于DSA(66% vs 58%,P<.001),在TASC D及膝下GLASS 4亚组中QISS MRI更易将病变降级。

要点

  • QISS MRI无需钆对比剂或电离辐射,可显示DSA未显影的「休眠血管」。
  • QISS MRI整体通畅节段检出率高于DSA,但整体TASC II与GLASS评分无显著差异。
  • 在TASC D与GLASS 4重度病变中,QISS MRI可显著降级,或影响治疗决策。

核心结论

  • 与当前金标准DSA相比,QISS MRI可识别更多通畅的膝下动脉节段。
  • QISS MRI可能使最重度动脉病变的TASC II与GLASS分级降低。
  • QISS MRI改善显影可能拓展复杂膝下病变CLTI患者的治疗选择范围。

研究设计与样本

  • 纳入接受QISS MRI与DSA检查的CLTI患者,共41例。
  • 由两名检查者分别判读两种模态影像。
  • 评估腘动脉与膝下动脉,每根血管分为三段按节段判为通畅或闭塞(胫腓干与足背动脉各计一段)。
  • 共分析570个血管节段,并进行TASC II与膝下GLASS评分比较。

主要发现

  • QISS MRI整体通畅节段比例为66%,DSA为58%(P < .001)。
  • 腓动脉通畅率QISS MRI 72% vs DSA 61%(P = .001)。
  • 胫后动脉通畅率QISS MRI 54% vs DSA 42%(P = .001)。
  • 胫前动脉通畅率QISS MRI 60% vs DSA 52%(P = .01)。
  • 足背动脉通畅率QISS MRI 65% vs DSA 38%。

关键数值与推荐

  • 整体TASC II与GLASS评分在DSA与QISS MRI间无显著差异。
  • TASC D与膝下GLASS 4病变亚组中,QISS MRI判读时血管显著更易被降级为较低级别病变。

临床怎么用

  • 对CLTI膝下动脉病变,可考虑QISS MRI补充评估,尤其适用于肾功能不全不宜使用碘对比剂者。
  • 在TASC D或GLASS 4等重度病变中,QISS MRI结果可能改变分级并影响血运重建策略选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Current imaging techniques are limited in their ability to accurately characterize below-the-knee diseased vessels. Digital subtraction angiography (DSA) remains the gold standard but may not visualize some vessels because it relies on nephrotoxic contrast that can fail to reach and opacify distal vessels. Quiescent-interval single shot (QISS) magnetic resonance imaging (MRI) images patients without exposure to nephrotoxic agents such as gadolinium or ionizing radiation and has been suggested to show "hibernating vessels" that are not visualized on DSA. The aim of this study is to evaluate whether QISS MRI would identify more patent vessels when compared with DSA, and whether this resulted in less severe Transatlantic Inter-Society Consensus (TASC) II and Global Limb Anatomic Staging System (GLASS) grades. METHODS: Patients with CLTI undergoing QISS MRI and DSA were included. Two examiners reviewed the imaging of each patient on both modalities. The vessels assessed were the popliteal and infrapopliteal arteries. All vessels were split into three sections (eg, anterior tibial artery [ATA]1, proximal; AT2, middle; and AT3, distal) and scored as either patent or occluded as individual segments (except the tibioperoneal and dorsalis pedis arteries, which were counted as one segment each). Following this, TASC II and infrapopliteal GLASS scoring was performed and compared between QISS MRI and DSA. RESULTS: A total of 41 patients were evaluated. Overall, 570 vessel segments were analyzed, with a significantly higher number of patent vessel segments found on QISS MRI compared with DSA (66% vs 58%; P < .001). On single-vessel analysis, there was a higher level of patency seen on QISS MRI compared with DSA in the peroneal (72% vs 61%; P = .001), posterior tibial (54% vs 42%; P = .001), anterior tibial (60% vs 52%; P = .01), and dorsalis pedis arteries (65% vs 38%). Overall TASC II and GLASS scoring did not significantly differ when comparing DSA and QISS MRI. Subgroup analysis of TASC D and infrapopliteal GLASS 4 lesions showed that vessels were significantly more likely to be downgraded to lower grade lesions when interpreting images using QISS MRI in comparison to DSA. CONCLUSIONS: QISS MRI can identify more patent vessel segments when compared with the current gold standard, DSA. This study also suggests that QISS MRI may result in lower grading on TASC II and GLASS scoring of the most severe spectrum of arterial disease. The improved visualization with QISS may expand the range of viable treatment options for patients with complex below-the-knee disease in chronic limb-threatening ischemia.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Crichton AB, Pomozi E, Drake M, et al. Noncontrast magnetic resonance angiography outperforms digital subtraction angiography in detecting hibernating below-the-knee arteries and downgrades Transatlantic Inter-Society Consensus and Global Limb Anatomic Staging System scores in chronic limb-threatening ischemia patients. J Vasc Surg. 2025. PMID: 41101708. doi:10.1016/j.jvs.2025.10.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。